The Janssen Pharmaceutical Companies of Johnson & Johnson announced today overall survival (OS) results from the Phase 3 ALCYONE study (Abstract #859), which showed the addition of DARZALEX®...

ONEOK, Inc. (NYSE: OKE) will participate in the Wells Fargo Midstream and Utility Symposium Dec. 11-12, 2019, in New York City. ONEOK management will present at the conference at 4:45 p.m. Eastern...

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an investigational, oral SYK/JAK inhibitor, in...

Naturally occurring chemicals in the global food supply are known to pose a burden on worldwide health. New studies have found that a certain foodborne toxin, in addition to its known health...

Experts at Hackensack Meridian Health John Theurer Cancer Center, a member of the Georgetown Lombardi Comprehensive Cancer Center consortium, participated in 46 studies presented over the last...